An Unexpected Finding of a Novel 21.9 kb Deletion (Heyuan deletion, β21.9kb) β-Thalassemia During HbA1c Measurements.

IF 0.7 4区 医学 Q4 MEDICAL LABORATORY TECHNOLOGY
Hanxian Liao, Liang Liang, Xingyuan Chen, Yu Zheng, Ying Huang, Youqiong Li
{"title":"An Unexpected Finding of a Novel 21.9 kb Deletion (Heyuan deletion, β21.9kb) β-Thalassemia During HbA1c Measurements.","authors":"Hanxian Liao, Liang Liang, Xingyuan Chen, Yu Zheng, Ying Huang, Youqiong Li","doi":"10.7754/Clin.Lab.2024.241035","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>β-thalassemia is predominantly caused by point mutations in the β-globin gene, whereas large deletions occur less frequently. Here, we described a novel 21.9 kb deletion found in a patient with β-thalassemia dur-ing HbA1c measurements.</p><p><strong>Methods: </strong>The proband was a 25-year-old female who came to the hospital with her husband for routine prenatal examinations. The hemoglobin A1c(HbA1c) was measured by high-performance liquid chromatography (HPLC). Hb analysis was performed by capillary electrophoresis (CE). Routine genetic analysis was carried out by PCR and reverse dot-blot (PCR-RDB) and Gap-PCR. Multiplex ligation-dependent probe amplification (MLPA) was used to screen the deletion in the β-globin chain. Based on the MLPA results, the break location of the deletion was determined by third-generation sequencing (TGS). Sanger sequencing verified the breakpoint in the Gap-PCR amplification products of TGS.</p><p><strong>Results: </strong>HbA1c measurements suggested an elevated HbF value (> 5%) by HPLC, and a retest of the Hb analysis showed an HbF value of 27.9%, and an Hb A2 value of 1.7% using CE. No mutations were detected by Gap-PCR and PCR-RDB. However, MLPA demostrated the presence of large fragment deletion in the β-globin chain. The positions of the deletion were located between 5,225,669 and 5,247,554 on chromosome 11 (chr11: 5,225,669-5,247,554; NG_000007.3:g.50,063-71,947 del) using TGS, spanning the length of 21,886 bp (21.9 kb deletion).</p><p><strong>Conclusions: </strong>This is the first report of the 21.9 kb deletion, so we named it Heyuan deletion for the place of origin of the proband. It presented with normal hematological parameters but an elevated HbF value.</p>","PeriodicalId":10384,"journal":{"name":"Clinical laboratory","volume":"71 4","pages":""},"PeriodicalIF":0.7000,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical laboratory","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.7754/Clin.Lab.2024.241035","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"MEDICAL LABORATORY TECHNOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: β-thalassemia is predominantly caused by point mutations in the β-globin gene, whereas large deletions occur less frequently. Here, we described a novel 21.9 kb deletion found in a patient with β-thalassemia dur-ing HbA1c measurements.

Methods: The proband was a 25-year-old female who came to the hospital with her husband for routine prenatal examinations. The hemoglobin A1c(HbA1c) was measured by high-performance liquid chromatography (HPLC). Hb analysis was performed by capillary electrophoresis (CE). Routine genetic analysis was carried out by PCR and reverse dot-blot (PCR-RDB) and Gap-PCR. Multiplex ligation-dependent probe amplification (MLPA) was used to screen the deletion in the β-globin chain. Based on the MLPA results, the break location of the deletion was determined by third-generation sequencing (TGS). Sanger sequencing verified the breakpoint in the Gap-PCR amplification products of TGS.

Results: HbA1c measurements suggested an elevated HbF value (> 5%) by HPLC, and a retest of the Hb analysis showed an HbF value of 27.9%, and an Hb A2 value of 1.7% using CE. No mutations were detected by Gap-PCR and PCR-RDB. However, MLPA demostrated the presence of large fragment deletion in the β-globin chain. The positions of the deletion were located between 5,225,669 and 5,247,554 on chromosome 11 (chr11: 5,225,669-5,247,554; NG_000007.3:g.50,063-71,947 del) using TGS, spanning the length of 21,886 bp (21.9 kb deletion).

Conclusions: This is the first report of the 21.9 kb deletion, so we named it Heyuan deletion for the place of origin of the proband. It presented with normal hematological parameters but an elevated HbF value.

在HbA1c测量中意外发现新的21.9kb缺失(Heyuan缺失,β21.9kb) β-地中海贫血。
背景:β-地中海贫血主要由β-珠蛋白基因的点突变引起,而大缺失发生的频率较低。在这里,我们描述了在HbA1c测量期间在β-地中海贫血患者中发现的一个新的21.9 kb缺失。方法:先证者为25岁女性,随丈夫来医院进行常规产前检查。采用高效液相色谱法测定血红蛋白A1c(HbA1c)。用毛细管电泳(CE)分析Hb。采用PCR、反向点印迹(PCR- rdb)和Gap-PCR进行常规遗传分析。多重连接依赖探针扩增(Multiplex lig- dependent probe amplification, MLPA)用于筛选β-珠蛋白链的缺失。根据MLPA结果,通过第三代测序(TGS)确定缺失的断裂位置。Sanger测序验证了TGS的Gap-PCR扩增产物的断点。结果:HbA1c检测显示HbF值升高(HbA1c升高5%),Hb分析的重新测试显示HbF值为27.9%,Hb A2值为1.7%。Gap-PCR和PCR-RDB均未检测到突变。然而,MLPA显示β-珠蛋白链中存在大片段缺失。缺失的位置位于第11染色体上的5,225,669和5,247,554之间(chr11: 5,225,669-5,247,554;NG_000007.3: g。50,063-71,947 del),全长21,886 bp(缺失21.9 kb)。结论:该缺失21.9 kb为首次报道,以先证者的起源地命名为河源缺失。血液学参数正常,但HbF值升高。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Clinical laboratory
Clinical laboratory 医学-医学实验技术
CiteScore
1.50
自引率
0.00%
发文量
494
审稿时长
3 months
期刊介绍: Clinical Laboratory is an international fully peer-reviewed journal covering all aspects of laboratory medicine and transfusion medicine. In addition to transfusion medicine topics Clinical Laboratory represents submissions concerning tissue transplantation and hematopoietic, cellular and gene therapies. The journal publishes original articles, review articles, posters, short reports, case studies and letters to the editor dealing with 1) the scientific background, implementation and diagnostic significance of laboratory methods employed in hospitals, blood banks and physicians'' offices and with 2) scientific, administrative and clinical aspects of transfusion medicine and 3) in addition to transfusion medicine topics Clinical Laboratory represents submissions concerning tissue transplantation and hematopoietic, cellular and gene therapies.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信